Roche to Buy InterMune for $8.3B, Adds Lung Drug

Aug. 25 (Bloomberg) -- Roche is strengthening its portfolio of medicines for respiratory ailments with an agreement to buy InterMune for $8.3 billion in cash. Olivia Sterns reports on “In The Loop.” (Source: Bloomberg)

Is Black Friday Fading to Grey?
14:31 - Huw McKay, senior international economist at Westpac, discusses the prospects for black Friday as consumer confidence declines. He speaks to Bloomberg's Angie Lau on "First Up." (Source: Bloomberg)
  • Putting a Lid on Emitters; China Tackles Pollution
  • COP21 Climate Conference: What to Expect From Paris
  • Are Markets Getting Used to Trading Geopolitics?